Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG.
Hatanaka
Y
Y
Department of Neurology, The University of Alabama, Birmingham, AL 35294, USA.
Hemmi
S
S
Morgan
M B
MB
Scheufele
M L
ML
Claussen
G C
GC
Wolfe
G I
GI
Oh
S J
SJ
D000328:Adult; D001323:Autoantibodies / Q000097:blood*; D015984:Causality; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D018450:Disease Progression; D004351:Drug Resistance / Q000276:immunology*; D004491:Edrophonium / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D009157:Myasthenia Gravis / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D018579:Patient Selection; D011237:Predictive Value of Tests; D011729:Pyridostigmine Bromide / Q000009:adverse effects; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology*; D011950:Receptors, Cholinergic / Q000276:immunology*
D001323:Autoantibodies; D002800:Cholinesterase Inhibitors; D011950:Receptors, Cholinergic; D004491:Edrophonium; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases; D011729:Pyridostigmine Bromide